Evidence map›Paper›PMID 42558151›Full record

ReviewJournal of neuroendovascular therapy2026

Global Perspectives on Endovascular Treatment of Intracranial Atherosclerotic Disease.

Huachen Zhang, Yiwen Xu, Xiaochuan Huo

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of neuroendovascular therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Huachen ZhangDepartment of Cerebral Vascular Disease, Neurological Disease Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Yiwen XuDepartment of Cerebral Vascular Disease, Neurological Disease Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Xiaochuan HuoDepartment of Cerebral Vascular Disease, Neurological Disease Center, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intracranial atherosclerotic disease (ICAD) is one of the important causes of ischemic stroke worldwide. With advances in patient selection, perioperative management, and endovascular device technology, endovascular therapy (EVT) has become an important research focus in ICAD as a potential adjunctive treatment strategy. This review summarizes the current global status of ICAD management, with particular attention to regional differences in epidemiological characteristics, endovascular treatment strategies, and perioperative medical management. This review may help improve understanding of the evolving treatment strategies and regional differences in ICAD management and provide references for future precision-based and individualized neurointerventional therapy.

Indexed as

endovascular therapyintracranial atherosclerotic diseaseintracranial stenosisneurointerventionstroke

Identifiers

PMID42558151
PMCPMC13437259

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.